Detalhe da pesquisa
1.
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Clin Cancer Res
; 11(22): 8180-5, 2005 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16299250
2.
Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses.
J Natl Cancer Inst
; 80(19): 1553-9, 1988 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-3143014
3.
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects.
J Natl Cancer Inst
; 80(12): 932-6, 1988 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-3398068
4.
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response.
J Natl Cancer Inst
; 80(12): 937-42, 1988 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-3398069
5.
Lack of T-cell immunity in humans with preexisting anti-mouse immunoglobulin reactivity.
Cancer Res
; 52(24): 6979-82, 1992 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-1458491
6.
Use of chlorotoxin for targeting of primary brain tumors.
Cancer Res
; 58(21): 4871-9, 1998 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9809993
7.
Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Cancer Res
; 55(23 Suppl): 5881s-5887s, 1995 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7493364
8.
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.
Cancer Res
; 51(20): 5461-6, 1991 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-1913665
9.
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
Cancer Res
; 53(19): 4555-62, 1993 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8402627
10.
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
Cancer Res
; 55(19): 4339-46, 1995 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7671245
11.
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.
Cancer Res
; 55(14): 3060-7, 1995 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7606728
12.
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.
Cancer Res
; 52(16): 4342-7, 1992 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-1643631
13.
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.
J Clin Oncol
; 19(13): 3234-43, 2001 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11432891
14.
Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
J Nucl Med
; 46(4): 642-51, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15809487
15.
Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Clin Cancer Res
; 5(10 Suppl): 2994s-3000s, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10541333
16.
Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Clin Cancer Res
; 5(10 Suppl): 3153s-3159s, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10541357
17.
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
Clin Cancer Res
; 9(4): 1323-32, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12684400
18.
Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
Clin Cancer Res
; 3(7): 1187-94, 1997 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-9815798
19.
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer.
Clin Cancer Res
; 5(10 Suppl): 3254s-3258s, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10541372
20.
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.
Clin Cancer Res
; 2(11): 1811-8, 1996 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9816134